Multicenter Study of Pomalidomide, Cyclophosphamide, and Dexamethasone in Relapsed Refractory Myeloma: Safety Profile in Mexican Population
Phase of Trial: Phase II
Latest Information Update: 23 Nov 2018
Price : $35 *
At a glance
- Drugs Cyclophosphamide (Primary) ; Dexamethasone (Primary) ; Pomalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 13 Nov 2018 Status changed from not yet recruiting to recruiting.
- 20 Aug 2018 Planned initiation date changed from 23 Jul 2018 to 14 Aug 2018.
- 01 Aug 2018 New trial record